Para-aminobenzoic acid (PABA).

Potassium aminobenzoate is the potassium salt of the identical p-aminobenzoic acid molecule. Dosing both counts as one aminobenzoate load, not two separate ingredients.

P-aminobenzoate is the middle ring that gut bacteria join to a pterin and glutamate to build folate. Humans lack that synthesis step, so folate is supplied directly while PABA only feeds the bacterial route.

Folic acid contains p-aminobenzoate bonded between the pteridine ring and glutamate, which is why the two are described together. The human body cannot assemble folate from free PABA, so the vitamin form carries the activity.

Most gut commensals build their own folate de novo, and para-aminobenzoic acid is the ring they start from. Supplying it alongside a live culture gives those organisms the aromatic precursor for their own folate synthesis. This is bacterial biochemistry, not a human pathway, so it says nothing about the folate status of the person taking it. The relationship is mechanistic rather than measured in a co-administration trial.

Some Lactobacillus plantarum strains carry a complete folate biosynthesis operon and others do not, so the response to added para-aminobenzoate is strain specific. Where the operon is intact, the aminobenzoate supplies the p-aminobenzoyl moiety of the folate molecule. The pairing is described at the level of microbial physiology. No human co-administration study grounds an intake effect.

Bifidobacteria are among the gut genera reported to release folate into the lumen, and that synthesis draws on a para-aminobenzoate precursor pool. Pairing the two is a substrate-and-organism logic rather than a clinical finding. Whether luminal folate produced this way reaches host circulation in a meaningful amount is not settled.

Saccharomyces species make their own folate and the pathway begins with the condensation of para-aminobenzoate. Supplying the precursor supports that yeast pathway during passage through the gut. The claim is about the organism's metabolism, not about the person's folate concentration.

Para-aminobenzoic acid forms the middle section of the folate structure, which is why older literature grouped it with the B vitamins. Humans have no dihydropteroate synthase, so the ring is a dead end and preformed folate has to come from diet or supplement. A formula that carries both should read para-aminobenzoate as an accessory compound, not as a folate source. Marking this as competitive flags the substitution error rather than any absorption conflict.

Para-aminobenzoate has appeared in B-complex products alongside pantothenic acid since the mid twentieth century, when both were catalogued as growth factors. The pairing is a formulation habit with a shared historical rationale, not a demonstrated metabolic interaction. It is worth stating plainly so a label reader knows why the two travel together.

Riboflavin and para-aminobenzoate co-occur in B-complex tablets, and both absorb in the near ultraviolet, which is why such blends are packaged in opaque containers. The shared handling requirement is a manufacturing fact rather than a biological synergy. Nothing here implies one improves the utilisation of the other.

Biotin and para-aminobenzoate were both isolated during the same era of growth-factor research and were folded into the same complex products. Their appearance together reflects that lineage. No cofactor relationship links them in human metabolism.

Methionine synthase hands a methyl group from 5-methyltetrahydrofolate to homocysteine using cobalamin, which is the point where folate chemistry and B12 chemistry meet. Para-aminobenzoate sits inside the folate structure but does not enter that cycle in humans. Stating the relationship makes clear where the aminobenzoate stops contributing.

The free aromatic amine of para-aminobenzoate oxidises on exposure to air and light, producing yellow discolouration in solution. Ascorbate is one of the reducing agents used in formulations that need to hold colour. This is a stability observation about the preparation, not a claim about what happens in the body.